Showing 6851-6860 of 18626 results for "".
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/Tune in to hear key takeaways and a breakdown of clinical data from a recent satellite symposium focused on the screening and treatment NASH.Surgical Evaluation and Treatment for Genetic Epilepsies
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/surgical-evaluation-and-treatment-for-genetic-epilepsies/32053/Genetic diagnosis can be useful in guiding surgical options for genetic epilepsies.Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
https://reachmd.com/programs/cme/optimizing-the-care-and-quality-of-life-for-patients-with-adpkd-part-3-management/12679/Once a patient is diagnosed with autosomal dominant polycystic kidney disease, how can we manage them?Another COVID-19 Vaccine Milestone Reached
https://reachmd.com/programs/the-drug-report/another-covid-19-vaccine-milestone-reached/12119/A second COVID-19 vaccination EUA approval marks another milestone in the global battle against the COVID-19 pandemic.The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
https://reachmd.com/clinical-practice/cardiology/the-overlooked-valve-why-women-with-aortic-stenosis-fall-through-the-cracks/39668/Explore sex-specific disparities in the diagnosis and treatment of symptomatic severe aortic stenosis. How could your clinical bias affect outcomes in women?DESTINY-Breast11: Clinically Relevant Adverse Events
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast11-clinically-relevant-adverse-events/48988/Tune in to explore the clinically relevant safety profile of T-DXd–based neoadjuvant therapy in high-risk HER2+ early breast cancer from DESTINY-Breast11.Ph+ CML and Treatment Adherence: Rethinking Nilotinib Formulations and Fasting Restrictions
https://reachmd.com/programs/medical-industry-feature/ph-cml-and-treatment-adherence-rethinking-nilotinib-formulations-and-fasting-restrictions/33045/Some patients taking nilotinib capsules may have difficulty fully adhering to the fasting restrictions or administration directions due to their schedules,1,2 and this is concerning as nilotinib has a exposure associated cardiotoxicity class effect.3 With the FDA approval of Danziten™ nilotinib tablAdvancing Care for Refractory Chronic Cough: Diagnostics and Emerging Therapies
https://reachmd.com/programs/deep-breaths-updates-chest/advancing-care-for-refractory-chronic-cough-diagnostics-and-emerging-therapies/32874/Refractory chronic cough (RCC) is a debilitating condition that is often misunderstood and underdiagnosed, leaving patients with persistent symptoms despite standard treatment. Hear from Drs. Michael Ghobrial, Anju Peters, and Michael Blaiss as they clarify the definition of RCC, outline essential dHarnessing the NAFLD/NASH Epidemic: Preparing for a New Treatment Paradigm
https://reachmd.com/programs/cme/harnessing-the-nafldnash-epidemic-preparing-for-a-new-treatment-paradigm/15673/Do you understand your role in determining which patient may benefit the most from NASH therapy?Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
https://reachmd.com/programs/cme/advancing-gmg-clinical-decisions-diagnosing-early-treating-smarter-and-caring-holistically-a-case-based-treatment-approach/36276/Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach